Epidemiology, prevention, and early detection of breast cancer

Current Opinion in Oncology

Volumn 12, Issue 6, 2000, Pages 515-520

  Alberg, Anthony J ^a   Singh, Sonia ^a   May, Joseph W ^a   Helzlsouer, Kathy J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; EARLY DIAGNOSIS; GENETIC POLYMORPHISM; HUMAN; INCIDENCE; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; PROGNOSIS; RISK FACTORS;

EID: 0034517246     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200011000-00001     Document Type: Review

References (59)

1. Cancer statistics, 2000
2. Global breast cancer mortality statistics
3. Epidemiology of contralateral breast cancer
4. Survival from contralateral breast cancer
5. Familial risks in second primary breast cancer based on a family cancer database
6. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations
7. Risk factors for breast cancer in women under 40 years
8. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2
9. Age at any full-term pregnancy and breast cancer risk
10. Lactation and breast carcinoma risk in a South African population
11. Adolescent reproductive events and subsequent breast cancer risk
12. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
13. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
14. HRT and breast cancer risk: A clue for interpreting available data
15. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
16. Breast cancer diagnosed during hormone replacement therapy
17. Hormone replacement therapy and breast cancer
18. Risk of breast cancer in women with palpable breast cysts: A prospective study
19. Association of age and reproductive factors with benign breast tissue composition
20. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood
21. Body fat distribution and obesity in pre- and postmenopausal breast cancer
22. Risk of breast cancer and organochlorine exposure
23. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations
24. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′-bis(p-chlorophenyl)ethylene
25. A prospective study of plasma ascorbic acid concentrations and breast cancer (United States)
26. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer
27. Dietary fat and risks of breast cancer: Combined analysis of 12 case-control studies
28. Fat intake and breast cancer risk in an area where fat intake is low: A case-control study in Indonesia
29. Occupational and leisure time physical activity and the risk of breast cancer
30. A prospective study of recreational physical activity and breast cancer risk
31. Lifetime exercise activity and breast cancer risk among post-menopausal women
32. Cigarette smoking and the risk of breast cancer
33. Cigarette smoking and breast cancer risk among young women (United States)
34. The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States)
35. Cigarette smoking and risk of benign proliferative epithelial disorders of the breast
36. Covariance of breast cancer incidence with smoking-, oestrogen- and diet-related cancers in pre- and postmenopausal women in Sweden
37. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan
38. Passive and active smoking and breast cancer risk in Canada 1994-97
39. Active and passive cigarette smoking and the occurrence of breast cancer
40. Relation of breast cancer with passive and active exposure to tobacco smoke
41. A systematic review of genetic polymorphisms and breast cancer risk
42. Genetic polymorphisms and risk of breast cancer
43. Molecular epidemiology of breast cancer: Genetic variation in steroid hormone metabolism
44. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk
45. Glutathione S-tranferase mu and theta polymorphisms and breast cancer susceptibility
46. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants
47. Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility
48. BRCA1 and BRCA2 and breast cancer incidence: A review
49. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: A decision analysis
50. Tamoxifen prevention of breast cancer: An instance of the fingerpost
51. Mammographic patterns as a predictive biomarker of breast cancer risk: Effect of tamoxifen
52. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer
53. Risk/benefit assessment of tamoxifen to prevent breast cancer: Still a work in progress?
54. Does this patient have breast cancer?
55. Continuing screening mammography in women aged 70 to 79 years
56. Hormone replacement therapy and accuracy of mammographic screening
57. Underutilization of mammography in older breast cancer survivors
58. Breast cancer screening in childhood cancer survivors